Related Experiment Video
Updated: Mar 21, 2026
10:59
Human Blastocyst Biopsy and Vitrification
Published on: July 26, 2019
24.0K
[Preimplantation Genetic Diagnosis by Blastocentesis: Problems and Perspectives]
Genetika
|May 18, 2016
Summary
Cell-free DNA found in blastocoele fluid shows promise for noninvasive preimplantation genetic diagnosis. This new method aligns well with traditional blastocyst analysis, advancing reproductive technologies and early human development genetics.
Area of Science:
- Reproductive Medicine
- Genetics
- Molecular Biology
Context:
- Preimplantation genetic diagnosis (PGD) traditionally involves invasive embryo biopsy.
- Emerging research explores non-invasive methods for genetic screening.
Purpose:
- To review the initial findings on cell-free DNA (cfDNA) in blastocoele fluid for PGD.
- To assess the efficacy of cfDNA analysis compared to blastocyst biopsy.
Summary:
- Cell-free DNA (cfDNA) detected in human blastocoele fluid offers a novel biological material for genetic analysis.
- Studies demonstrate high concordance between cfDNA-based molecular karyotyping and results from direct blastocyst cell analysis.
- This suggests cfDNA is a viable alternative for genetic assessment.
Impact:
- Paves the way for non-invasive preimplantation genetic diagnosis, reducing risks associated with embryo biopsy.
- Potential to significantly advance assisted reproductive technologies (ART) and the study of early human development.
- Opens new avenues for understanding chromosomal and genetic diseases during early human ontogenesis.
